Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2212 of 5804
-
Can text messages ease appearance anxiety? new study aims to find out
Symptom relief Recruiting nowThe current study aims to explore the efficacy of a text message based safety behavior fading intervention compared to a progressive muscle relaxation intervention for appearance concerns.
Phase: NA • Sponsor: Florida State University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could a common diabetes drug tame gout flares?
Disease control Recruiting nowSAVE-Care (Sodium Glucose Cotransporter-2 inhibitors \[SGLT2i\] As Novel Gout Care) Trial is a double-blind randomized placebo-controlled trial (RCT) designed to assess the effect of empagliflozin on serum urate \[SU\] levels of gout patients, as well as levels of highly-sensitiv…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New program aims to ease tough End-of-Life talks for cancer patients
Symptom relief Recruiting nowThe aims of this study are to (1) assess the feasibility, acceptability, and usability of the ROCKS intervention among patients with advanced cancer and their family caregivers through a randomized controlled trial in a cancer center setting; (2) evaluate the preliminary efficacy…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New cancer drug CTX-10726 enters first human tests
Disease control Recruiting nowThis is a Phase 1, open-label, first-in-human study of CTX-10726 monotherapy in patients with metastatic or locally advanced malignancies. The study will be conducted in 2 Cohorts: Cohort 1 Dose Escalation and Cohort 2 Dose Expansion.
Phase: PHASE1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug CS-1103 tested as potential fentanyl overdose treatment
Disease control Recruiting nowThe purpose of the study is to evaluate the safety, tolerability, pharmacokinetics, and efficacy of CS-1103 (1,000 mg), given by intravenous (IV) infusion in healthy participants in the presence of a clinically relevant dose of fentanyl (200 μg, IV), with naloxone blockade (400 μ…
Phase: PHASE2 • Sponsor: Clear Scientific, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Pilot fish study: bringing HIV prevention to routine clinic visits
Prevention Recruiting nowThe goal of this clinical trial is to understand what patients and physicians think about providing medications to prevent HIV transmission to patients in a family planning clinic. These medications are known as pre-exposure prophylaxis, or PrEP. The main questions to answer are:…
Phase: NA • Sponsor: Women and Infants Hospital of Rhode Island • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
New drug aims to keep platelets up during breast cancer chemo
Disease control Not yet recruitingThis study is a prospective clinical study enrolling breast cancer patients at high risk of chemotherapy-induced thrombocytopenia (CTIT). It aims to investigate the efficacy and safety of hetrombopag in the secondary prophylaxis of CTIT. Breast cancer patients with histologicall…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug IEV407 takes on advanced breast cancer in early trial
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability and preliminary activity of IEV407 as a single agent and in combination with endocrine therapy (fulvestrant or letrozole) in patients with advanced hormone receptor positive (HR+), human epidermal growth factor rec…
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New imaging tracers could spot Hard-to-Find cancers
Diagnosis Recruiting nowThis is an open-label, first-in-human, exploratory Phase 0 study evaluating the safety and diagnostic imaging performance of the DOTA-STR-17126 theranostic pair in patients with advanced or metastatic breast or prostate cancer. The study investigates \[68Ga\]Ga-DOTA-STR-17126 for…
Phase: EARLY_PHASE1 • Sponsor: Integrated Haematology and Oncology Network • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New shingles vaccine trial aims for safer protection in adults 40+
⭐️ VACCINE ⭐️ ENROLLING_BY_INVITATIONTo evaluate the safety and tolerability of different dosages of recombinant zoster vaccine (CHO cell) when administered to adults aged 40 years and older.
Phase: PHASE1 • Sponsor: Changchun BCHT Biotechnology Co. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:05 UTC
-
Oxygen straight to the gut: new hope for bowel disease?
Disease control Recruiting nowThis multicenter, randomized, double-blind, placebo-controlled clinical trial aimed to investigate the efficacy and safety of gut oxygen therapy in the treatment of ischemic-hypoxic bowel disease using deep intestinal catheterization as a targeted route for gut oxygen delivery.
Phase: NA • Sponsor: The Second Hospital of Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New scan could spot hidden prostate cancer
Diagnosis Recruiting nowThe aim of this study is to assess the safety and dosimetry of imaging with \[68Ga\]Ga-OncoACP3 in patients with prostate cancer.
Phase: PHASE1 • Sponsor: Philogen S.p.A. • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New hope for Tough-to-Treat blood cancer: targeted drug trial opens
Disease control Recruiting nowThis phase II trial tests the effect of mirdametinib in treating patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back after a period of improvement (relapsed) or that has not responded to previous treatment (refractory). Mirdamet…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can mindfulness ease psychosis in teens and young adults?
Symptom relief Recruiting nowFEEL-GOOD is a prospective multi-site single-blinded randomized controlled trial in young inpatients with acute early psychosis. Participants are randomized 1:1 to FEEL-GOOD plus treatment as usual (TAU) or TAU alone. The intervention consists of one individual preparatory sessio…
Phase: NA • Sponsor: Stephanie Mehl • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Probiotics may speed recovery from eye disease, new study hopes
Disease control Recruiting nowTo investigate the potential association between gut microbiota and central serous chorioretinopathy (CSC), clinical observations have indicated that patients with CSC frequently present with chronic gastrointestinal symptoms. This observation has led to the hypothesis that CSC m…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New study tests botox injections to ease nerve pain in amputee veterans
Symptom relief Not yet recruitingPatients with combat-related amputations frequently experience chronic neuroma pain that may interfere with rehabilitation, prosthesis use, mobility, sleep, and quality of life. Ultrasound-guided botulinum toxin type A injection has emerged as a potential treatment option for per…
Phase: NA • Sponsor: Ukrainian Society of Regional Anesthesia and Pain Therapy • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Pre-Surgery carb drink may speed liver transplant recovery
Symptom relief Recruiting nowThe aim of the study is to evaluate the effect of preoperative oral carbohydrate loading on postoperative outcomes in liver transplant recipients. The results of this study may contribute to improving recovery after liver transplantation and shortening postoperative hospital stay…
Phase: NA • Sponsor: Medical University of Warsaw • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New procedure aims to ease stubborn back and buttock pain
Symptom relief Recruiting nowThe purpose of this study is to evaluate the real-world performance, safety and efficacy of the TRAQ System.
Sponsor: PainTEQ, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Which stent is best for unblocking bile ducts in cancer patients?
Disease control Recruiting nowMetallic stents are commonly used for biliary drainage in patients with unresectable malignant distal biliary obstruction. However, it is unclear whether a 12-mm partially covered self-expandable metallic stent or a 12-mm bare self-expandable metallic stent provides better effect…
Phase: NA • Sponsor: Chung-Ang University Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Virtual workouts may protect heart health in breast cancer patients on chemo
Symptom relief Recruiting nowThis clinical trial studies whether a healthy living intervention (HLI), with or without a physical activity intervention (PAI), helps maintain the ability to exercise, heart health, and quality of life in breast cancer patients who are scheduled to receive chemotherapy treatment…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC